• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丙型病毒性肝炎

Viral hepatitis C.

作者信息

Czepiel Jacek, Biesiada Grazyna, Mach Tomasz

机构信息

Department of Gastroenterology, Hepatology and Infectious Diseases, Jagiellonian University Medical College, Kraków, Poland.

出版信息

Pol Arch Med Wewn. 2008 Dec;118(12):734-40.

PMID:19202952
Abstract

Hepatitis C is caused by the hepatitis C virus (HCV) infection. According to World Health Organization data, 3% of the world population (approximately 170 million people) is infected with HCV; in Poland there are over 700,000. Over 70% of those infected manifest no symptoms in the acute phase of the disease, and in about 70-80% the acute phase progresses into a chronic form. Patients with symptoms in the acute phase of HCV infection most commonly present with unspecific signs and symptoms that may develop in other viral liver infections, e.g. malaise, fatigue, abdominal pain, mild hepato- and splenomegaly and arthralgia. These symptoms usually persist for 2 to 12 weeks. In the chronic phase a subset of patients complain of malaise, nausea, abdominal pain and itching. With time, chronic hepatitis C may develop into liver cirrhosis. The basic diagnostic methods in HCV infection involve determination of anti-HCV antibodies using the ELISA immunoassay and examination of HCV-RNA with the RT-PCR method. The current treatment of HCV infection involves administration of pegylated interferon a and ribavirin over a period of 48 weeks in HCV-1 genotype infection, and 24 weeks for HCV-2 and 3 genotypes. Effectiveness of therapy depends on the HCV genotype. HCV elimination can be achieved in 78% of patients with HCV-2 and 3 genotypes, and in 55% of patients with HCV-1 genotype.

摘要

丙型肝炎由丙型肝炎病毒(HCV)感染引起。根据世界卫生组织的数据,全球3%的人口(约1.7亿人)感染了HCV;在波兰,感染人数超过70万。超过70%的感染者在疾病急性期没有症状,约70 - 80%的急性期会发展为慢性形式。HCV感染急性期有症状的患者最常见的是非特异性体征和症状,这些症状也可能出现在其他病毒性肝脏感染中,如不适、乏力、腹痛、轻度肝脾肿大和关节痛。这些症状通常持续2至12周。在慢性期,一部分患者会抱怨不适、恶心、腹痛和瘙痒。随着时间的推移,慢性丙型肝炎可能发展为肝硬化。HCV感染的基本诊断方法包括使用ELISA免疫测定法检测抗HCV抗体以及用RT-PCR方法检测HCV-RNA。目前HCV感染的治疗方法是,对于HCV-1基因型感染,给予聚乙二醇化干扰素α和利巴韦林治疗48周,对于HCV-2和3基因型则治疗24周。治疗效果取决于HCV基因型。HCV-2和3基因型患者中有78%可以实现病毒清除,HCV-1基因型患者中有55%可以实现病毒清除。

相似文献

1
Viral hepatitis C.丙型病毒性肝炎
Pol Arch Med Wewn. 2008 Dec;118(12):734-40.
2
Ribavirin in the treatment of hepatitis C.利巴韦林治疗丙型肝炎
Anticancer Res. 2005 Mar-Apr;25(2B):1315-20.
3
Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.儿童慢性丙型肝炎干扰素α治疗效果的研究。
Med Sci Monit. 2000 Sep-Oct;6(5):964-70.
4
Human cytomegalovirus infection inhibits response of chronic hepatitis-C-virus-infected patients to interferon-based therapy.人巨细胞病毒感染抑制慢性丙型肝炎病毒感染患者对基于干扰素治疗的反应。
J Gastroenterol Hepatol. 2011 Jan;26(1):55-62. doi: 10.1111/j.1440-1746.2010.06319.x.
5
Chronic hepatitis C responds poorly to combination therapy in chronic hepatis B carriers.慢性丙型肝炎对慢性乙型肝炎携带者的联合治疗反应不佳。
Neth J Med. 2008 May;66(5):191-5.
6
Undetectable hepatitis C virus RNA at week 4 as predictor of sustained virological response in HIV patients with chronic hepatitis C.第4周丙型肝炎病毒RNA检测不到作为慢性丙型肝炎合并HIV患者持续病毒学应答的预测指标
AIDS. 2008 Jan 2;22(1):15-21. doi: 10.1097/QAD.0b013e3282f1da99.
7
How to use virological tools for the optimal management of chronic hepatitis C.如何利用病毒学工具优化慢性丙型肝炎的管理。
Liver Int. 2011 Jan;31 Suppl 1:3-12. doi: 10.1111/j.1478-3231.2010.02398.x.
8
2011 European Association of the Study of the Liver hepatitis C virus clinical practice guidelines.2011 年欧洲肝脏研究学会丙型肝炎病毒临床实践指南。
Liver Int. 2012 Feb;32 Suppl 1:2-8. doi: 10.1111/j.1478-3231.2011.02703.x.
9
Chronic hepatitis C virus infection in renal transplant: treatment and outcome.肾移植受者的慢性丙型肝炎病毒感染:治疗与转归
Clin Transplant. 2006 Nov-Dec;20(6):677-83. doi: 10.1111/j.1399-0012.2006.00534.x.
10
[Chronic hepatitis C virus infection: clinical picture and treatment possibilities].[慢性丙型肝炎病毒感染:临床表现及治疗可能性]
G Ital Nefrol. 2012 Jan-Feb;29 Suppl 54:S103-8.

引用本文的文献

1
Elevated miR-33a and miR-224 in steatotic chronic hepatitis C liver biopsies.脂肪变性的慢性丙型肝炎肝活检中miR-33a和miR-224水平升高。
World J Gastroenterol. 2014 Nov 7;20(41):15343-50. doi: 10.3748/wjg.v20.i41.15343.
2
Chemiluminescent microparticle immunoassay based detection and prevalence of HCV infection in district Peshawar Pakistan.基于化学发光微粒免疫分析的巴基斯坦白沙瓦地区丙型肝炎病毒感染检测与流行情况
Virol J. 2014 Jul 12;11:127. doi: 10.1186/1743-422X-11-127.
3
Role of viral and host factors in interferon based therapy of hepatitis C virus infection.
病毒和宿主因素在丙型肝炎病毒感染的干扰素治疗中的作用。
Virol J. 2013 Oct 1;10:299. doi: 10.1186/1743-422X-10-299.
4
Hepatitis C Virus Infection in HIV Positive Attendees of Shiraz Behavioral Diseases Consultation Center in Southern Iran.伊朗南部设拉子行为疾病咨询中心的HIV阳性患者中的丙型肝炎病毒感染情况
Indian J Community Med. 2013 Apr;38(2):86-91. doi: 10.4103/0970-0218.112437.
5
Current status and future directions in the management of chronic hepatitis C.慢性丙型肝炎管理的现状与未来方向。
Virol J. 2012 Mar 2;9:57. doi: 10.1186/1743-422X-9-57.
6
An orally available, small-molecule interferon inhibits viral replication.一种可口服的小分子干扰素可抑制病毒复制。
Sci Rep. 2012;2:259. doi: 10.1038/srep00259. Epub 2012 Feb 10.
7
Improving antigenicity of the recombinant hepatitis C virus core protein via random mutagenesis.通过随机诱变提高重组丙型肝炎病毒核心蛋白的抗原性。
J Biomed Biotechnol. 2011;2011:359042. doi: 10.1155/2011/359042. Epub 2011 Aug 29.
8
Signal transduction pathways in liver and the influence of hepatitis C virus infection on their activities.肝脏中的信号转导通路以及丙型肝炎病毒感染对其活性的影响。
World J Gastroenterol. 2009 May 14;15(18):2184-9. doi: 10.3748/wjg.15.2184.